6th ICHNO Abstract Book

6TH ICHNO CONTENT

THURSDAY 16 MARCH 2017 Keynote lecture

Immunotherapy for head and neck cancer: integrating the fourth modality....................................Abs. 1 State of the art in robotic surgery ...........................................................................................Abs. 2 Symposium Prognostic modelling.......................................................................................................... Abs. 3-5 Proffered papers Proffered papers 1............................................................................................................. Abs. 6-9 Randomised trials New data from randomised trials . .................................................................................... Abs. 10-13 Symposium Reductions of radiation induced toxicities .......................................................................... Abs. 14-16 New imaging techniques ......................................................................................................Abs. 17 HNC Biomarkers - how do we translate biology into useful assays for clinical care? . .....................Abs. 18 Proffered papers Proffered papers 2......................................................................................................... Abs. 19-22 Symposium New developments in surgery.......................................................................................... Abs. 23-25 Interactive tumour board session Limited T4a larynx cancer Poster discussion Poster discussion ........................................................................................................... Abs. 26-34 Symposium New developments in systemic treatment . ........................................................................ Abs. 35-37 SATURDAY 18 MARS 2017 Keynote lecture Clinical implementation of adaptive radiotherapy: challenges ahead ...........................................Abs. 38 Symposium Adenoid cystic carcinoma ................................................................................................ Abs. 39-40 Proffered papers Proffered papers 3 ......................................................................................................... Abs. 42-45 Debate Early stage HPV related oropharyngeal cancer should not be treated with radiotherapy anymore . ..... Abs. 46-49 Conference remarks Concluding remarks Posters Multidisciplinary management . ........................................................................................ Abs. 50-76 Innovative treatments .................................................................................................... Abs. 78-96 Biology, HPV and molecular targeting . ............................................................................ Abs. 97-108 Imaging and radiomics ................................................................................................Abs. 109-116 Supportive care, quality of life, rehabilitation ..................................................................Abs. 117-130 Minimal invasive and reconstructive surgery ...................................................................Abs. 131-134 Epidemiology and prevention . ......................................................................................Abs. 135-137 Salivary gland, skull base, skin and thyroid cancers .........................................................Abs. 138-143 Special requirements for elderly patients . ......................................................................Abs. 144-150 Immunodiagnosis and immunotherapy ................................................................................. Abs. 151 FRIDAY 17 MARCH 2017 Keynote lecture

AUTHOR INDEX .................................................................................................................... page 74